Coronary artery disease is associated with higher epicardial Retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue

Clinical Endocrinology

Volumn 76, Issue 1, 2012, Pages 51-58

  Salgado Somoza, Antonio ^a   Teijeira Fernández, Elvis ^b   Rubio, José ^c   Couso, Elena ^d   González Juanatey, José R ^a,b   Eiras, Sonia ^a  

^a Sanitary Research Institute   (Spain)

^b Department of Cardiology and Medicine   (Spain)

^c Department of Heart Surgery ^*  (Spain)

^d Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; RETINOL BINDING PROTEIN 4;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIABETIC PATIENT; EPICARDIUM; EXPLANT; FEMALE; HEART SURGERY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADIPOSE TISSUE, WHITE; AGED; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MALE; PERICARDIUM; REAL-TIME POLYMERASE CHAIN REACTION; RETINOL-BINDING PROTEINS, PLASMA; SUBCUTANEOUS FAT; TISSUE CULTURE TECHNIQUES;

EID: 83455164042     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04140.x     Document Type: Article

References (37)

1. Mathieu, P., Poirier, P., Pibarot, P., et al. (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53, 577-584.
2. Berg, A.H., &, Scherer, P.E., (2005) Adipose tissue, inflammation, and cardiovascular disease. Circulation Research 96, 939-949. (Pubitemid 40712793)
3. Goralski, K.B., &, Sinal, C.J., (2007) Type 2 diabetes and cardiovascular disease: getting to the fat of the matter. Canadian Journal of Physiology and Pharmacology 85, 113-132. (Pubitemid 46996110)
4. Gonzalez-Juanatey, J.R., Paz, F.L., Eiras, S., et al. (2009) Adipokines as novel cardiovascular disease markers. Pathological and clinical considerations. Revista Espanola de Cardiologia 62 (Suppl. 2), 9-16.
5. Tsutsumi, C., Okuno, M., Tannous, L., et al. (1992) Retinoids and retinoid-binding protein expression in rat adipocytes. The Journal of Biological Chemistry 267, 1805-1810.
6. Yang, Q., Graham, T.E., Mody, N., et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356-362. (Pubitemid 41065039)
7. D'Onofrio, C., Colantuoni, V., &, Cortese, R., (1985) Structure and cell-specific expression of a cloned human retinol binding protein gene: the 5′-flanking region contains hepatoma specific transcriptional signals. EMBO Journal 4, 1981-1989.
8. Broch, M., Ramirez, R., Auguet, M.T., et al. (2010) Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4). Physiological Research 59, 299-303.
9. Stefan, N., Hennige, A.M., Staiger, H., et al. (2007) High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30, 1173-1178. (Pubitemid 46684644)
10. Graham, T.E., Yang, Q., Bluher, M., et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New England Journal of Medicine 354, 2552-2563. (Pubitemid 43882351)
11. Lee, J.W., Im, J.A., Park, K.D., et al. (2009) Retinol binding protein 4 and insulin resistance in apparently healthy elderly subjects. Clinica Chimica Acta 400, 30-32.
12. Jia, W., Wu, H., Bao, Y., et al. (2007) Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 92, 3224-3229. (Pubitemid 47236396)
13. Kloting, N., Graham, T.E., Berndt, J., et al. (2007) Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metabolism 6, 79-87. (Pubitemid 46995778)
14. von Eynatten, M., Lepper, P.M., Liu, D., et al. (2007) Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 50, 1930-1937. (Pubitemid 47222861)
15. Yao-Borengasser, A., Varma, V., Bodles, A.M., et al. (2007) Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. Journal of Clinical Endocrinology and Metabolism 92, 2590-2597. (Pubitemid 47037362)
16. Solini, A., Santini, E., Madec, S., et al. (2009) Retinol-binding protein-4 in women with untreated essential hypertension. American Journal of Hypertension 22, 1001-1006.
17. Makino, S., Fujiwara, M., Suzukawa, K., et al. (2009) Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Hormone and Metabolic Research 41, 221-226.
18. Ingelsson, E., Sundstrom, J., Melhus, H., et al. (2009) Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 206, 239-244.
19. Lee, J.W., Im, J.A., Lee, H.R., et al. (2007) Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women. Obesity (Silver Spring) 15, 2225-2232.
20. Rissanen, J., Hudson, R., &, Ross, R., (1994) Visceral adiposity, androgens, and plasma lipids in obese men. Metabolism 43, 1318-1323. (Pubitemid 24307949)
21. Sacks, H.S., &, Fain, J.N., (2007) Human epicardial adipose tissue: a review. American Heart Journal 153, 907-917. (Pubitemid 46809849)
22. Chaowalit, N., Somers, V.K., Pellikka, P.A., et al. (2007) Adipose tissue of atrial septum as a marker of coronary artery disease. Chest 132, 817-822.
23. Mazurek, T., Zhang, L., Zalewski, A., et al. (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108, 2460-2466. (Pubitemid 37444406)
24. Eiras, S., Teijeira-Fernandez, E., Shamagian, L.G., et al. (2008) Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine 43, 174-180.
25. Teijeira-Fernandez, E., Eiras, S., Grigorian-Shamagian, L., et al. (2008) Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension. Journal of Human Hypertension 22, 856-863.
26. Salgado-Somoza, A., Teijeira-Fernandez, E., Fernandez, A.L., et al. (2010) Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. American Journal of Physiology. Heart and Circulatory Physiology 299, H202-H209.
27. Tamori, Y., Sakaue, H., &, Kasuga, M., (2006) RBP4, an unexpected adipokine. Nature Medicine 12, 30-31; discussion 31. (Pubitemid 43050050)
28. Silaghi, A., Achard, V., Paulmyer-Lacroix, O., et al. (2007) Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status. American Journal of Physiology. Endocrinology and Metabolism 293, E1443-E1450. (Pubitemid 350106615)
29. Sacks, H.S., Fain, J.N., Holman, B., et al. (2009) Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. Journal of Clinical Endocrinology and Metabolism 94, 3611-3615.
30. Dutour, A., Achard, V., Sell, H., et al. (2010) Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease. Journal of Clinical Endocrinology and Metabolism 95, 963-967.
31. Spiroglou, S.G., Kostopoulos, CG, Varakis, JN, et al. (2010) Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. Journal of Atherosclerosis and Thrombosis 17, 115-130.
32. Langheim, S., Dreas, L., Veschini, L., et al. (2010) Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. American Journal of Physiology. Heart and Circulatory Physiology 298, H746-H753.
33. Broch, M., Ramirez, R., Auguet, M.T., et al. (2009) Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4). Physiological Research 59, 299-303.
34. Bobbert, T., Raila, J., Schwarz, F., et al. (2010) Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 213, 549-551.
35. Graham, T.E., &, Kahn, B.B., (2007) Tissue-specific alterations of glucose transport and molecular mechanisms of intertissue communication in obesity and type 2 diabetes. Hormone and Metabolic Research 39, 717-721. (Pubitemid 350099818)
36. McLaughlin, T., Sherman, A., Tsao, P., et al. (2007) Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 50, 1707-1715. (Pubitemid 47036653)
37. Tejero, M.E., Proffitt, J.M., Cole, S.A., et al. (2004) Quantitative genetic analysis of glucose transporter 4 mRNA levels in baboon adipose. Obesity Research 12, 1652-1657. (Pubitemid 41132474)